Encompass Health Corp - 01 Jul 2022 Form 4 Insider Report for Enhabit, Inc. (EHAB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Jul 2022, 19:11:45 UTC
Prior SEC filing
17 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Leasure

Key filing fact

Encompass Health Corp filed Form 4 for Enhabit, Inc. (EHAB) on 06 Jul 2022.

Key facts

  • This page summarizes Encompass Health Corp's Form 4 filing for Enhabit, Inc. (EHAB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Jul 2022, 19:11.

Change

  • Previous filing in this sequence was filed on 17 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHAB transaction

Common Stock

Other

Transaction value
$0
Shares
-3,853,248
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Jul 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Encompass Health Corp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

In connection with the spin-of of Enhabit, Inc. ("Enhabit") from Encompass Health Corporation ("Encompass"), on June 30, 2022, Encompass distributed 100% of the outstanding shares of common stock, $0.01 par value, of Enhabit to the holders of record of Encompass common stock at the close of business on June 24, 2022, the record date for the distribution.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .